128
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Patterns of Non-Infectious Scleritis across a Tertiary Eye Care Network Using the Indigenously Developed Electronic Medical Record System-eyeSmart

, MDORCID Icon, , MDORCID Icon, , B Opt, , MD, , MDORCID Icon, , MDORCID Icon, , D.O & , MD show all
Pages 1733-1739 | Received 30 Oct 2020, Accepted 08 Jun 2021, Published online: 13 Jul 2021

References

  • Watson P, Hayreh S. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163–191. doi:10.1136/bjo.60.3.163.
  • de la Maza MS, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology. 2012;119(1):51–58. doi:10.1016/j.ophtha.2011.07.043.
  • Diaz JD, Sobol EK, Gritz DC. Treatment and management of scleral disorders. Surv Ophthalmol. 2016;61(6):702–717. doi:10.1016/j.survophthal.2016.06.002.
  • Singh A, Jadhav S, Roopashree M. Factors to overcoming barriers affecting electronic medical record usage by physicians. Indian J Commun Med. 2020;45(2):168. doi:10.4103/ijcm.IJCM_478_19.
  • Wang SJ, Middleton B, Prosser LA, et al. A cost-benefit analysis of electronic medical records in primary care. Am J Med. 2003;114(5):397–403. doi:10.1016/S0002-9343(03)00057-3.
  • Das AV, Kammari P, Ranganath Vadapalli SB. Big data and the eyeSmart electronic medical record system-An 8-year experience from a three-tier eye care network in India. Indian J Ophthalmol. 2020;68(3):427. doi:10.4103/ijo.IJO_710_19.
  • Tanaka R, Kaburaki T, Ohtomo K, et al. Clinical characteristics and ocular complications of patients with scleritis in Japanese. Jpn J Ophthalmol. 2018;62(4):517–524. doi:10.1007/s10384-018-0600-y.
  • Chen EJ, Bin Ismail MA, Mi H, et al. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – report 1: epidemiology and classification. Ocul Immunol Inflamm. 2018;26(5):732–746. doi:10.1080/09273948.2016.1249376.
  • Ahn SJ, Oh JY, Kim MK, et al. Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol. 2010;24(6):331–335. doi:10.3341/kjo.2010.24.6.331.
  • Thong LP, Rogers SL, Hart CT, et al. Epidemiology of episcleritis and scleritis in urban Australia. Clin Exp Ophthalmol. 2020;48:757–766. doi:10.1111/ceo.13761.
  • Lane J, Nyugen E, Morrison J, et al. Clinical features of scleritis across the Asia-Pacific region. Ocul Immunol Inflamm. 2019;27(6):920–926. doi:10.1080/09273948.2018.1484496.
  • Berchicci L, Miserocchi E, Di Nicola M, et al. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Eur J Ophthalmol. 2014;24(3):293–298. doi:10.5301/ejo.5000394.
  • de la Maza MS, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43–50. doi:10.1016/j.ophtha.2011.07.013.
  • Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469–476. doi:10.1016/S0002-9394(00)00710-8.
  • Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501–506. doi:10.1016/j.ophtha.2003.06.006.
  • Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009;148(6):946–950. doi:10.1016/j.ajo.2009.07.021.
  • Wieringa WG, Wieringa JE, Ten Dam-van Loon NH, et al. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology. 2013;120(2):379–386. doi:10.1016/j.ophtha.2012.08.005.
  • Xu TT, Reynolds MM, Hodge DO, et al. Epidemiology and Clinical characteristics of episcleritis and scleritis in Olmsted County, Minnesota. Am J Ophthalmol. 2020;217:317–324. doi:10.1016/j.ajo.2020.04.043.
  • Kumar A, Ghose A, Biswas J, et al. Clinical profile of patients with posterior scleritis: a report from Eastern India. Indian J Ophthalmol. 2018;66(8):1109. doi:10.4103/ijo.IJO_121_18.
  • McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106(12):2380–2386. doi:10.1016/S0161-6420(99)90543-2.
  • Chen Y-W, Poon Y-C, Yu H-J, et al. Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan. Taiwan J Ophthalmol. 2015;5(1):19–22. doi:10.1016/j.tjo.2014.10.004.
  • Homayounfar G, Borkar DS, Tham VM, et al. Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study. Ocul Immunol Inflamm. 2014;22(5):403–404. doi:10.3109/09273948.2013.854394.
  • Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013;32(12):1562–1566. doi:10.1097/ICO.0b013e3182a407c3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.